Cargando…
First report of computational protein–ligand docking to evaluate susceptibility to HIV integrase inhibitors in HIV-infected Iranian patients
BACKGROUND: Iran has recently included integrase (INT) inhibitors (INTIs) in the first‐line treatment regimen in human immunodeficiency virus (HIV)-infected patients. However, there is no bioinformatics data to elaborate the impact of resistance-associated mutations (RAMs) and naturally occurring po...
Autores principales: | Ghasabi, Farzane, Hashempour, Ava, Khodadad, Nastaran, Bemani, Soudabeh, Keshani, Parisa, Shekiba, Mohamad Javad, Hasanshahi, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968007/ https://www.ncbi.nlm.nih.gov/pubmed/35368742 http://dx.doi.org/10.1016/j.bbrep.2022.101254 |
Ejemplares similares
-
Transmitted Drug Resistance Against Integrase Strand Transfer Inhibitors in Iranian HIV-Infected Naïve Patients
por: Hashempour, Ava, et al.
Publicado: (2023) -
First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients
por: Hasanshahi, Zahra, et al.
Publicado: (2021) -
The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein
por: Dehghani, Behzad, et al.
Publicado: (2019) -
Bioinformatics Analysis of Domain 1 of HCV-Core Protein: Iran
por: Dehghani, Behzad, et al.
Publicado: (2019) -
Docking studies of flavonoid derivatives as potent HIV-1 integrase inhibitors
por: Premjanu, N, et al.
Publicado: (2014)